medigraphic.com
ISSN 1561-3070 (Electronic)

2018, Number 2

<< Back Next >>

Rev Cub Oftal 2018; 31 (2)

Short-term outcomes of trabeculectomy associated to sulfur hexafluoride

Fumero GFY, Fernández AL, Cárdenas CD, Piloto DI, Díaz ÁY, Padilla GCM

Language: Spanish
References: 31
Page: 1-11
PDF size: 161.79 Kb.


ABSTRACT

Objective: describe the short-term results of trabeculectomy associated to sulfur hexafluoride.
Methods: an analytical case-control study was conducted of 30 eyes (30 patients) of which 15 eyes (15 patients) underwent trabeculectomy with mitomycin C and sulfur hexafluoride (case group) and 15 eyes (15 patients) underwent trabeculectomy with mitomycin C (control group). An evaluation was performed of the best corrected visual acuity, preoperative and postoperative intraocular pressure and surgical complications. Follow-up extended for up to three months after surgery.
Results: mean preoperative best corrected visual acuity was 88 VAR (± 16; 79-97) for the case group and 86 VAR (± 16; 77-95) for the control group (p= 0,628). Mean intraocular pressure was 28.8 mmHg (± 6.3; 25.2-32.3) and 30 mmHg (± 9.5; 24.8- 35.3) respectively (p= 0.868). At three months, mean best corrected visual acuity was similar in the two groups: 88 VAR (± 13; 80-95) and 84 VAR (± 17; 74-93) respectively; (p= 0.659); whereas intraocular pressure was 14.6 mmHg (± 2.8; 13.0- 16.3) and 15.7 mmHg (± 5.4; 12.7-18.8) respectively (p= 0.707). The most common complications were cataract (6.7 %) and uveitis (6,7 %) in the case group, and athalamia (19.9 %), hyphema (13.3 %) and Tenon's cyst (13.3 %) in the control group. Cellular density dropped to 2 004 cell/mm2 (± 87) in the case group and 1 886 cell/mm2 (± 66) in the control group (p= 0.494).
Conclusions: short-term visual outcomes, hypotensive effects and surgical complications were similar in trabeculectomy with mitomycin C with or without associated sulfur hexafluoride. Medium-term studies are required to evaluate the hypotensive effect of sulfur hexafluoride.


REFERENCES

  1. Tham Y, Li X, Wong T, Quigley H, Aung T, Cheng C. Global prevalence of glaucoma and projections of glaucoma burden through 2 040. Ophthalmology. 2014;121(11):2081-90.

  2. Hernández Silva JR, Río Torres M, Padilla González CM. Resultados del RACSS en Ciudad de La Habana, Cuba, 2005. Rev Cubana Oftalmol. 2006 [citado 26 de enero de 2017];19(1):[aprox 13 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0864- 21762006000100001&lng=es

  3. Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M, et al. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol. 2002;120(10):1268-79.

  4. Fernández L, Martin Y. Trabeculectomía. En: Fernández L. Glaucoma. Temas quirúrgicos. La Habana: ECIMED; 2013. p. 55-84.

  5. Ahmed I. AGS Surgery Day Lecture 2015 on MIGS 2.0. 2015 [citado 11 de noviembre de 2017]. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475547/

  6. Vila-Arteaga J, Vila-Mascarell E. Ordenando las técnicas quirúrgicas del glaucoma. Arch Soc Esp Oftalmol. 2014 [citado 11 de noviembre de 2017];89(8):[aprox. 9 p.]. Disponible en: http://www.elsevier.es/es-revista-archivos-sociedad-espanola-oftalmologia-296/

  7. American Academy of Ophthalmology. Glaucoma. San Francisco: Basic and clinical Science Course. American Academy of Ophthalmology; 2014.

  8. Fernández L, Padilla CM, Obret I, Piloto I, Fumero FY. Factores pronósticos del fallo de la trabeculectomía en una población cubana. Arch Soc Esp Oftalmol. 2015 [citado 26 de enero de 2017];90(12):[aprox 12 p.]. Disponible en: http://dx.doi.org/10.1016/j.oftale.2015.12.005

  9. Güerri N, Calvo P. Actualización del tratamiento de las ampollas encapsuladas postrabeculectomía. Arch Soc Esp Oftalmol. 2011;86(6):173-5.

  10. Fumero González FY, Cárdenas Chacón D, Vidal Castillo M, Fernández Argones L, Piloto Díaz I, Obret Mendive I. Revisión con agujas y uso de Mitomicina C en ampollas de filtración encapsuladas. Rev Cubana Oftalmol. 2016 [citado 7 de julio de 2017];29(2):[aprox. 12 p.]. Disponible en: http://www.revoftalmologia.sld.cu/index.php/oftalmologia/article/view/385/html_206

  11. Kurtz S, Leibovitch I. Combined perfluoropropane gas and viscoelastic material injection for anterior chamber reformation following trabeculectomy. Br J Ophthalmol. 2002;86(11):1225-7.

  12. Beigi B, O´Keefe M, Algawi K, Acheson R, Burke J. Sulphur hexafluoride in the treatment of flat anterior chamber following trabeculectomy. Eye. 1997;11:672-6.

  13. Weinstein O, Oshry T, Tessler Z, Lifshitz T. Use of sulphur hexafluoride for anterior chamber reformation following trabeculectomy. Br J Ophthalmol. 1998;82(10):1220.

  14. Tsai WT. The decomposition products of sulfur hexafluoride (SF6): Reviews of environmental and health risk analysis. J Fluorine Chem. 2007;128(11):1345-52.

  15. Abreu-Reyes JA. Uso del hexafluoruro de azufre en la cirugía filtrante del glaucoma (editorial). Arch Soc Esp Oftalmol. 2006;81(2):667-70.

  16. Abreu-Reyes JA, Aguilar-Estévez JJ. Manejo de la atalamia posoperatoria: uso de la combinación hialuronato sódico y hexafluoruro de azufre. An Instit Barraq. 2006;35(3):139-45.

  17. Law SK, Mansury AM, Vasudev D, Caprioli J. Effects of combimed cataract surgery and trabeculectomy with mitomycin C on ocular dimensions. Br J Ophthalmol. 2005;89(8):1021-5.

  18. Francis BA, Hong B, Winarko J, Kawji S, Dustin L, Chopra V. Vision loss and recovery after trabeculectomy: risk and associated risk factors Arch Ophthalmol. 2011;129(8):1011-7.

  19. Infante Y, Cabeza E, Pina M, Guelmes N. Resultados de la trabeculectomía en pacientes glaucomatosos. Sancti Spíritus 2009. Gac Méd Espirit. 2011[citado 26 de enero de 2017];13(1):[aprox. 13 p.]. Disponible en: http://bvs.sld.cu/revistas/gme/pub/vol.13.%281%29_01/vol.13.1.01.pdf

  20. Alemán I, Armengol Y, Suárez V, Morejón A. Evolución y resultados del glaucoma por cierre angular primario. Rev Méd Electrón. 2011 [citado 2017 de febrero de 2005];33(4):[aprox. 14 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1684- 18242011000400002

  21. Collaborative Normal-Tension Glaucoma Study Group. The effectiveness of intraocular pressure reduction in the treatment of normal - tension glaucoma. Am J Ophthalmol. 1998;126(4):498-505.

  22. Gedde SJ, Schiffman JC, Feuer WJ. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789-803.

  23. Cárdenas Díaz T, Corcho Arévalo Y, Capote Cabrera A. Caracterización del endotelio corneal en pacientes con indicación de cirugía de catarata. Rev Cubana Oftalmol. 2013;26(1):39-47.

  24. Laing R. Specular microscopy. In: Krachmer MJ, Mannis MJ, Holland EJ. Cornea. St. Louis: Mosby; 1997. p. 313-34.

  25. García L, Castillo Gómez A, García Feijóo J, Macías Benítez JM, García Sánchez J. Estudio del endotelio corneal tras la cirugía del glaucoma. Arch Soc Esp Oftalmol. 2000 [citado 26 de enero de 2017];(2):[aprox. 7 p.]. Disponible en: http://www.oftalmo.com/seo/archivos/articulo.php?idSolicitud=616&numR=2&mesR= 2&anioR=2000&idR=30

  26. Vega Higuera JC. Trabeculectomía y endotelio. Rev Fac Med Univers Nac Col. 1995;43(3):46-147.

  27. Smith DL, Skuta GL, Lindenmuth KA, Musch DC, Bergstrom TJ. The effect of glaucoma filtering surgery on corneal endothelial cell density. Ophthalmic Surg. 1991;22(5):251-5.

  28. Sihota R, Sharma T, Agarwal HC. Intraoperative mitomycin C and the corneal endothelium. Act Ophthalmol Scand. 1998;76(1):80-2.

  29. Stanley-Candraya M, Martínez C. C3F8 intracameral para tratar desprendimiento de Descemet luego de cirugía de catarata. Rev Mex Oftalmol. 2012;86:131-5.

  30. Sharifipour F, Nassiri S, Idan A. Descemet's membrane detachment management following trabeculectomy. J Ophthalmic Vis Res. 2016;11(3):323-32.

  31. Geyer O, Segev E, Steinberg JM, Buckman G. Stabilization of post-trabeculectomy flat anterior chamber with Healon and sulfur hexafluoride. J Cataract Refract Surg. 2003;29(10):2026-8.




2020     |     www.medigraphic.com